The clinical trial software market has witnessed significant growth with rising demand for clinical trial management systems from pharmaceutical and biotechnology companies. Clinical trial software helps in automating routine tasks such as patient recruitment and randomization, workflow management, supply chain management and others. It allows centralization of data, reduces billing issues and ensures regulatory compliance. The software automates and streamlines processes to save costs and accelerate clinical development programs.
The Clinical Trial Software Market is estimated to be valued at US$ 0.9 Bn in 2024 and is expected to exhibit a CAGR of 14.% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the clinical trial software are Advarra, Arisglobal, AssistRx, Calyx, Clario and Among Others.
Key players operating in the clinical trial software are focused on increasing their cloud-based offerings and partnerships with CROs to cater to growing demand from pharma companies. Advarra, Clario and Arisglobal are leading global players in the market.
The increasing research and development activities in pharmaceutical and biotechnology industries are driving demand for clinical trial software. It is estimated that global clinical trial spending will grow at a CAGR of 5% during 2024-2030.
Clinical trial software vendors are offering technological advanced solutions like automated reporting tools, machine learning capabilities, and blockchain technology to make clinical trials more efficient. These innovations aim to accelerate trial procedures and make processes compliant.
Market Trends
Growing adoption of cloud-based clinical trial management systems: Cloud deployment reduces upfront capital requirement and offers flexibility, scalability and collaborative features fueling adoption.
Increasing focus on real-world evidence generation: Vendors are integrating real world data with electronic health records to power clinical decision making using real world evidence.
Market Opportunities
Integrations with eConsenting and patient engagement solutions: Integrating patient recruitment and consenting platforms with trial management software can improve site performance and patient retention.
Data analytics and AI powered tools: Leveraging AI/ML capabilities for predictive analytics, automated reporting and stratification of patient subgroups presents growth opportunity.
Impact Of COVID-19 On Clinical Trial Software Market Growth
The COVID-19 pandemic has significantly impacted the clinical trial software market growth. Due to the nationwide lockdowns imposed across various countries, the recruitment of new patients in clinical trials was severely hampered. Patient enrollment witnessed a steep decline as healthcare facilities prioritized COVID-19 treatment. This disrupted ongoing clinical trial activities and slowed down new trials. However, with rapid digitalization and work from home becoming the norm, the clinical trial software solutions gained prominence. Pharmaceutical companies and contract research organizations increasingly adopted these software tools to remotely monitor ongoing trials and ensure patient safety. With regulations being relaxed for virtual/decentralized clinical trials, the use of e-signature, telehealth, and other remote patient engagement functionalities of clinical trial management systems increased significantly. As the pandemic is expected to accelerate the shift to virtual and hybrid models, the post-COVID scenario is anticipated to drive higher adoption of these digital solutions. However, the immediate impact was short term decline in revenue of clinical trial software vendors.
Among geographical regions, North America currently holds the largest share of the clinical trial software market in terms of value. This is attributed to presence of major pharmaceutical companies and medical device manufacturers actively conducting clinical trials in the region. Additionally, favorable regulations and technological advancements have propelled clinical trials activities in the US and Canada. However, Asia Pacific region is expected be the fastest growing market during the forecast period. Favorable government policies supporting clinical research and widespread focus on pharmaceutical development are fueling market growth in APAC countries like China, Japan and India. Emerging Asian economies are attracting huge investments from global players to set up clinical research facilities owing to low cost and large patient pools. This is expected to boost regional market revenues in the coming years.
Get more insights on this topic: https://www.pressreleasebulletin.com/clinical-trial-software-market-is-estimated-to-witness-high-growth-owing-to-big-data-analytics/
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc.
(https://www.linkedin.com/in/ravina-pandya-1a3984191)
What Are The Key Data Covered In This Clinical Trial Software Market Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Clinical Trial Software Market's growth between 2024 and 2031.
:- Accurate calculation of the size of the Clinical Trial Software Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Clinical Trial Software Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Clinical Trial Software Market vendors
FAQ’s
Q.1 What are the main factors influencing the Clinical Trial Software Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Clinical Trial Software Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Clinical Trial Software Market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Comments
0 comment